World's Best Scientists 2026 revealed!
Award Badge
Immunology
USA
2026

D-Index & Metrics

Immunology

D-Index
154
Citations
102789
World Ranking
109
National Ranking
69

Medicine

D-Index
154
Citations
102800
World Ranking
993
National Ranking
566

Research.com Recognitions

  • 2026 - Research.com Immunology in United States Leader Award
  • 2025 - Research.com Immunology in United States Leader Award
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

William W. Busse is affiliated with the University of Wisconsin-Madison in the United States and has contributed extensively to the field of medicine, with a particular focus on physiology, pulmonary and respiratory medicine, immunology, and immunology and allergy. Their research encompasses a wide range of topics, notably asthma and respiratory diseases, respiratory and cough-related research, IL-33, ST2, and ILC pathways, allergic rhinitis and sensitization, eosinophilic esophagitis, inhalation and respiratory drug delivery, and pediatric health and respiratory diseases.

Busse's recent publications include the following:

  • Understanding the key issues in the treatment of uncontrolled persistent asthma with type 2 inflammation, 2021, European Respiratory Journal
  • Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis, 2021, The Lancet Respiratory Medicine

Other notable recent papers within their collaborative network include:

  • Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2, 2020, Journal of Allergy and Clinical Immunology
  • Type 2 immunity in the skin and lungs, 2020, Allergy
  • Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial, 2022, The Lancet

William W. Busse has frequently collaborated with a number of co-authors, including Daniel J. Jackson, Leonard B. Bacharier, Gurjit K. Khurana Hershey, James E. Gern, and Meyer Kattan.

The scientist's work has been published extensively in prominent journals. The most frequent publication venues include:

  • Journal of Allergy and Clinical Immunology
  • The Journal of Allergy and Clinical Immunology In Practice
  • Annals of Allergy Asthma & Immunology
  • American Journal of Respiratory and Critical Care Medicine
  • Brain Behavior and Immunity

Busse's research contributions span over 300 published works in medicine, with significant specializations distributed as 117 publications in physiology, 78 in pulmonary and respiratory medicine, 43 in immunology, 34 in immunology and allergy, and 22 in surgery.

William W. Busse is recognized for their membership in the Association of American Physicians.

Best Publications

  • Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

    J. Bousquet;H. J. Schünemann;B. Samolinski;P. Demoly

  • Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

    J. Bousquet;N. Khaltaev;A. A. Cruz;J. Denburg

  • Asthma. From bronchoconstriction to airways inflammation and remodeling.

    Jean Bousquet;Peter K. Jeffery;William W. Busse;Malcolm Johnson

  • Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program

    Wendy C. Moore;Deborah A. Meyers;Sally E. Wenzel;W. Gerald Teague

  • Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study.

    Eric D. Bateman;Homer A. Boushey;Jean Bousquet;William W. Busse

  • Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma

    Mario Castro;Jonathan Corren;Ian D. Pavord;Jorge Maspero

  • An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.

    Helen K. Reddel;D. Robin Taylor;Eric D. Bateman;Louis-Philippe Boulet

  • Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

    J Mark FitzGerald;Eugene R Bleecker;Parameswaran Nair;Stephanie Korn

  • Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma.

    William Busse;Jonathan Corren;Bobby Quentin Lanier;Margaret McAlary

  • Efficacy and safety of inhaled corticosteroids. New developments.

    Peter J. Barnes;Søren Pedersen;William W. Busse

  • Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children

    William W. Busse;Wayne J. Morgan;Peter J. Gergen;Herman E. Mitchell

  • Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program

    Wendy C. Moore;Eugene R. Bleecker;Douglas Curran-Everett;Serpil C. Erzurum

  • Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study.

    Nicola A. Hanania;Sally Wenzel;Karin Rosén;Hsin-Ju Hsieh

  • Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma

    Jean Bousquet;Jean Bousquet;Eva Mantzouranis;Alvaro A. Cruz;Nadia Aït-Khaled

  • Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations

    Dara G. Torgerson;Dara G. Torgerson;Elizabeth J. Ampleford;Grace Y. Chiu;W. James Gauderman

  • Role of viral respiratory infections in asthma and asthma exacerbations

    William W Busse;Robert F Lemanske;James E Gern

  • A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.

    Patrick Flood-Page;Cheri Swenson;Isidore Faiferman;John Matthews

  • Effects of Treatment with Anti-immunoglobulin E Antibody Omalizumab on Airway Inflammation in Allergic Asthma

    Ratko Djukanović;Susan J. Wilson;Monica Kraft;Nizar N. Jarjour

  • Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.

    Jonathan A. Leff;William W. Busse;David Pearlman;Edwin A. Bronsky

  • Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial

    Unknown

  • Allergy, rhinitis, other respiratory diseases Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma

    William Busse;Jonathan Corren;Bobby Quentin Lanier;Margaret McAlary

Frequent Co-Authors

Eugene R. Bleecker
Eugene R. Bleecker University of Arizona
Sally E. Wenzel
Sally E. Wenzel University of Pittsburgh
James E. Gern
James E. Gern University of Wisconsin–Madison
Stanley J. Szefler
Stanley J. Szefler University of Colorado Denver
Nizar N. Jarjour
Nizar N. Jarjour University of Wisconsin–Madison
Mario Castro
Mario Castro Washington University in St. Louis
Harold S. Nelson
Harold S. Nelson National Jewish Health
Serpil C. Erzurum
Serpil C. Erzurum Cleveland Clinic Lerner College of Medicine
Donald Y.M. Leung
Donald Y.M. Leung National Jewish Health
Eric D. Bateman
Eric D. Bateman University of Cape Town

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, related healthcare degrees can open diverse career opportunities. Many students transition into nursing to apply their immunology knowledge in clinical settings. Programs like online BSN programs for non nurses provide a flexible pathway for individuals without prior nursing experience to quickly enter the field.

If you're looking to accelerate your nursing career, consider 12-month accelerated nursing programs that allow for fast-tracked education without compromising quality. These programs are designed for motivated students ready to meet the demands of an intensive curriculum.

For those exploring entry-level nursing roles, researching LPN schools easy to get into can be a practical starting point. Licensed Practical Nurses play a vital role in patient care, often working alongside immunology specialists.

Finally, advancing to advanced practice roles such as nurse practitioners is possible through programs identified by what is the easiest NP program. These offer specialized training that can complement an immunology background and expand career horizons.

Best Scientists Citing William W. Busse

Trending Scientists

Recently Published Articles